Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Genetics
  4. Research progress on long non‑coding RNAs in non‑infectious spinal diseases (Review)

Research progress on long non‑coding RNAs in non‑infectious spinal diseases (Review)

MOLECULAR MEDICINE REPORTS, 2024 · DOI: 10.3892/mmr.2024.13288 · Published: June 18, 2024

GeneticsSpinal Disorders

Simple Explanation

Spinal diseases like intervertebral disc degeneration (IDD) significantly reduce patients' quality of life, and current treatments only alleviate symptoms without curing the diseases. Long non-coding RNAs (lncRNAs) play a role in spinal diseases like IDD, but their mechanisms are not fully understood, presenting challenges for therapeutic use. This review discusses lncRNAs' sources, classification, and functions, highlighting their involvement in spinal diseases such as IDD and their potential for treatment.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review Article

Key Findings

  • 1
    lncRNAs are involved in the occurrence and development of spinal diseases, including IDD, ankylosing spondylitis, and spinal cord injury.
  • 2
    lncRNAs can affect the synthesis and degradation of the ECM, cell death, inflammation and ageing of NP cells in IDD.
  • 3
    Differentially expressed lncRNAs play a regulatory role in SCI, providing new ideas for its treatment.

Research Summary

The review explains the classification and functions of lncRNAs and their roles in IDD, AS and SCI, noting their impact on ECM, cell death, inflammation, and aging in spinal diseases. Thousands of lncRNAs show differential expression in IDD compared to normal tissues, yet only a fraction have been studied, necessitating further research. While lncRNA application in spinal disease treatment is preclinical, their success in treating malignant diseases suggests great potential for clinical application in treating spinal diseases like IDD.

Practical Implications

Therapeutic Targets

lncRNAs can be potential therapeutic targets for spinal diseases.

Drug Development

Understanding lncRNA mechanisms may aid in developing new drugs.

Personalized Medicine

lncRNA expression profiles could inform personalized treatment strategies.

Study Limitations

  • 1
    Current research mainly focuses on cells, rats, and human degenerative tissues.
  • 2
    Studies on more advanced large animals such as monkeys are lacking.
  • 3
    The impact of regulating lncRNA expression cannot be accurately controlled.

Your Feedback

Was this summary helpful?

Back to Genetics